P

PZ Cormay SA
WSE:CRM

Watchlist Manager
PZ Cormay SA
WSE:CRM
Watchlist
Price: 0.395 PLN -1% Market Closed
Market Cap: zł33.3m

Operating Margin

-1.7%
Current
Improving
by 3%
vs 3-y average of -4.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1.7%
=
Operating Income
zł-1.7m
/
Revenue
zł95.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1.7%
=
Operating Income
zł-1.7m
/
Revenue
zł95.5m

Peer Comparison

Country Company Market Cap Operating
Margin
PL
PZ Cormay SA
WSE:CRM
33.6m PLN
Loading...
JP
Hoya Corp
TSE:7741
8.6T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.8B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
36.4B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
120.8B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.1B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
KR
HLB Inc
KOSDAQ:028300
8.7T KRW
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF
Loading...

Market Distribution

Lower than 70% of companies in Poland
Percentile
30th
Based on 835 companies
30th percentile
-1.7%
Low
-10 083 900% — -1.5%
Typical Range
-1.5% — 11.7%
High
11.7% — 195 905.3%
Distribution Statistics
Poland
Min -10 083 900%
30th Percentile -1.5%
Median 5.4%
70th Percentile 11.7%
Max 195 905.3%

PZ Cormay SA
Glance View

Market Cap
33.3m PLN
Industry
Health Care

PZ Cormay SA engages in the manufacture of diagnostic reagents and laboratory equipment. The company is headquartered in Lomianki, Woj. Mazowieckie and currently employs 218 full-time employees. The company went IPO on 2008-08-20. The firm is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. The company offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.

CRM Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1.7%
=
Operating Income
zł-1.7m
/
Revenue
zł95.5m
What is PZ Cormay SA's current Operating Margin?

The current Operating Margin for PZ Cormay SA is -1.7%, which is above its 3-year median of -4.7%.

How has Operating Margin changed over time?

Over the last 3 years, PZ Cormay SA’s Operating Margin has increased from -2.5% to -1.7%. During this period, it reached a low of -7.7% on Jun 30, 2024 and a high of -1.7% on Oct 30, 2025.

Back to Top